Your Input: | |||||
EP300 | E1A binding protein p300. (2175 aa) | ||||
BBC3 | BCL2 binding component 3. (270 aa) | ||||
ENSPTRP00000081714 | annotation not available (310 aa) | ||||
SHISA5 | Shisa family member 5. (248 aa) | ||||
BBC3-2 | BCL2 binding component 3. (270 aa) | ||||
PHLDA3 | Pleckstrin homology like domain family A member 3. (127 aa) | ||||
USP28 | USP28 isoform 2; Belongs to the peptidase C19 family. (1192 aa) | ||||
ATAD5 | ATPase family AAA domain containing 5. (1844 aa) | ||||
TP53 | Cellular tumor antigen p53; Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression; Belongs to the p53 family. (393 aa) | ||||
PYCARD | PYD and CARD domain containing. (195 aa) | ||||
CK820_G0024820 | PPP2R5C isoform 26. (479 aa) | ||||
RPS27L | 40S ribosomal protein S27. (100 aa) | ||||
SIRT1-2 | Sirtuin 1. (751 aa) | ||||
NUPR1 | Nuclear protein 1, transcriptional regulator. (82 aa) | ||||
HIPK1 | HIPK1 isoform 10. (1210 aa) | ||||
SIRT1 | SIRT1 isoform 2. (751 aa) | ||||
DDIT4 | DNA-damage-inducible transcript 4. (232 aa) | ||||
TMEM109 | Transmembrane protein 109. (243 aa) | ||||
BRCA2 | Breast cancer 2, early onset. (3418 aa) | ||||
PPP2R5C | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit; The B regulatory subunit might modulate substrate selectivity and catalytic activity, and also might direct the localization of the catalytic enzyme to a particular subcellular compartment. (579 aa) | ||||
ELL3 | Elongation factor RNA polymerase II-like 3. (397 aa) | ||||
PML | PML isoform 6. (836 aa) | ||||
CHEK2 | Checkpoint kinase 2. (586 aa) | ||||
MSH2 | DNA mismatch repair protein; Component of the post-replicative DNA mismatch repair system (MMR). (865 aa) | ||||
BAG6 | BAG6 isoform 3. (1162 aa) | ||||
DYRK2 | Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2. (601 aa) | ||||
IFI16 | IFI16 isoform 4. (733 aa) | ||||
TP73 | Tumor protein p73; Participates in the apoptotic response to DNA damage. Isoforms containing the transactivation domain are pro-apoptotic, isoforms lacking the domain are anti-apoptotic and block the function of p53 and transactivating p73 isoforms. May be a tumor suppressor protein. (636 aa) | ||||
SNW1 | SNW domain containing 1. (571 aa) | ||||
CDKN1A | Cyclin-dependent kinase inhibitor 1A (P21, Cip1). (276 aa) | ||||
AEN | Apoptosis enhancing nuclease. (325 aa) | ||||
TOPORS | Topoisomerase I binding, arginine/serine-rich, E3 ubiquitin protein ligase. (1045 aa) | ||||
BCL3 | BCL3 transcription coactivator. (454 aa) | ||||
CDIP1 | Chromosome 16 open reading frame 5. (208 aa) | ||||
HIPK2 | Homeodomain interacting protein kinase 2. (1198 aa) | ||||
TP63 | Tumor protein 63 (p63); Acts as a sequence specific DNA binding transcriptional activator or repressor. The isoforms contain a varying set of transactivation and auto-regulating transactivation inhibiting domains thus showing an isoform specific activity. May be required in conjunction with TP73/p73 for initiation of p53/TP53 dependent apoptosis in response to genotoxic insults and the presence of activated oncogenes. (680 aa) |